PMID: 284378Feb 1, 1979

Stimulation of benzodiazepine receptor binding by gamma-aminobutyric acid

Proceedings of the National Academy of Sciences of the United States of America
M Karobath, G Sperk

Abstract

The effect of the neurotransmitter gamma-aminobutyric acid (GABA) on high-affinity binding of benzodiazepines to brain membranes has been investigated. GABA stimulated [3H]diazepam binding by more than 100% when extensively washed membranes from brain tissue were used. This GABA-stimulated benzodiazepine binding occurred in all brain regions examined. The stimulation was specific for GABA agonist. It was inhibited by the GABA receptor blocker bicuculline methiodide. A large number of compounds structurally closely related to GABA but without direct effect on the GABA receptor failed to enhance [3H]diazepam binding. The stimulation of benzodiazepine binding was caused by an increase in affinity; the number of binding sites remained unchanged. Half-maximal activation of [3H]diazepam binding occurred in the presence of 300 nM muscimol or 900 nM GABA. beta-Guanidinopropionic acid and imidazoleacetic acid were much weaker activators. It is suggested that the described stimulation of benzodiazepine high-affinity binding is mediated by a receptor for GABA. This site of GABA action exhibits different properties when compared to GABA receptors, as characterized by high-affinity binding of GABA agonists.

Citations

Jan 1, 1981·Psychopharmacology·P J MarangosP Skolnick
Sep 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·S ArbillaS Z Langer
Jun 1, 1983·Pflügers Archiv : European journal of physiology·M Riley, C N Scholfield
Oct 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·L TurskiK H Sontag
Feb 1, 1983·Neurochemical Research·R Sherman-Gold, Y Dudai
Jan 1, 1986·Journal of Neural Transmission·J WildmannH Matthaei
Jun 1, 1985·Italian Journal of Neurological Sciences·P GuarneriF Piccoli
Aug 15, 1983·Biochemical Pharmacology·F J EhlertH I Yamamura
Mar 19, 1984·Brain Research·B KrespanH M Geller
Oct 15, 1979·European Journal of Pharmacology·M Karobath, M Lippitsch
Oct 3, 1980·European Journal of Pharmacology·R D Howells, E J Simon
Jul 11, 1980·European Journal of Pharmacology·B L WaszczakJ R Walters
Mar 21, 1980·European Journal of Pharmacology·P Supavilai, M Karobath
Jun 1, 1984·European Journal of Pharmacology·G Drexler, Werner Sieghart
Mar 2, 1984·European Journal of Pharmacology·S Simasko, A Horita
Nov 14, 1989·European Journal of Pharmacology·M Urbancic, T J Marczynski
Feb 25, 1980·Life Sciences·M Gavish, S H Snyder
Feb 25, 1980·Life Sciences·T Asano, N Ogasawara
Nov 10, 1980·Life Sciences·H Kageyama, A Kurosawa
Apr 7, 1980·Life Sciences·T Asano, N Ogasawara
Apr 6, 1981·Life Sciences·I YokoiT Yanagihara
Aug 31, 1981·Life Sciences·J E Heusner, H B Bosmann
Apr 22, 1985·Life Sciences·D J Sanger
Jan 1, 1988·Life Sciences·C E KetelaarsJ Bruinvels
Jun 1, 1991·Pharmacology, Biochemistry, and Behavior·V H Sethy, T T Oien
Jan 1, 1982·Neurochemistry International·P SupavilaiM Karobath
Jan 1, 1983·Neurochemistry International·F V DeFeudis
Jan 1, 1983·Neurochemistry International·F V DeFeudis
Jan 1, 1988·Neurochemistry International·M HillmannB C Shanley
Jan 1, 1990·Neurochemistry International·S F de Plazas, de N Alba Mitridate
Jan 1, 1990·Neurochemistry International·M R MazzoniA Lucacchini
Jan 1, 1982·Neurobiology of Aging·P GuarneriG Biggio
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·I L Martin
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·I L Martin
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·M G CordaG Biggio
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·A MatsushitaS Takada
Dec 1, 1979·Neuroscience Letters·H C Rosenberg, T H Chiu
Nov 1, 1980·Neuroscience Letters·M Willow, I G Morgan
Nov 30, 1982·Neuroscience Letters·J H SkerrittG A Johnston
Apr 6, 1990·Neuroscience Letters·L M OrensanzI Fernández
Jan 1, 1986·General Pharmacology·N Matsokis, Y Dalezios
Jan 1, 1982·Psychoneuroendocrinology·A N EliasM K Grossman
Jan 1, 1991·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·J L DavalA Pereira de Vasconcelos
Jan 1, 1991·Epilepsy Research·D N JohnsonB F Kilpatrick
Aug 15, 1998·Journal of Ethnopharmacology·J F LiaoC F Chen
Jun 8, 2001·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·D PericićK Mirković
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·H MöhlerJ Y Wu
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·M Gavish, S H Snyder
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J P ChambonC G Wermuth
Dec 1, 1996·British Journal of Pharmacology·A M Hosie, D B Sattelle
Jun 1, 1991·Alcoholism, Clinical and Experimental Research·K J Buck, R A Harris
Jan 1, 1982·Neuropharmacology·P J Marangos, J N Crawley
Jan 1, 1980·Progress in Neurobiology·F A Henn, S W Henn
Nov 1, 1988·Neurochemical Research·V VargaS S Oja
Dec 3, 2014·European Journal of Medicinal Chemistry·Mansi GargRaj Kumar
Jan 1, 1983·Pharmacological Research Communications·F V DeFeudis
Jun 1, 1983·Journal of Neurochemistry·W F White, S R Snodgrass
Oct 1, 1983·Journal of Neurochemistry·Claudia MartiniA Lucacchini
Dec 1, 1985·Journal of Neurochemistry·P J SyapinE P Noble
Oct 1, 1981·Journal of Neurochemistry·W KuhnH Przuntek
Apr 1, 1987·Journal of Neurochemistry·P J SyapinE P Noble
Jul 1, 1981·Journal of Neurochemistry·R W Olsen
Aug 31, 1990·Biochemical and Biophysical Research Communications·M FontanaD Cavallini
Jul 16, 2015·Journal of Medicinal Chemistry·Elisabetta BarresiClaudia Martini
Oct 16, 1980·Nature·M Gavish, S H Snyder
Dec 24, 1981·Nature·H Möhler, J G Richards
Jul 17, 1980·Nature·Werner Sieghart, M Karobath
Jan 1, 1981·Medicinal Research Reviews·P Skolnick, S M Paul
Nov 1, 1981·Journal of Neurochemistry·M Willow, G A Johnston
Jul 1, 1984·Medicinal Research Reviews·M Simonyi
Jul 1, 1988·Journal of Neurochemistry·Y ItoI K Ho
Sep 1, 1984·Journal of Neurochemistry·S TelangS J Enna
Sep 1, 1984·Acta Pharmacologica Et Toxicologica·U Tacke, C Braestrup
Apr 1, 1985·Journal of Neurochemistry·E H Wong, L L Iversen
Oct 1, 1984·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·J N Nestoros
Jan 1, 1990·Annals of the New York Academy of Sciences·F V DeFeudis

Related Concepts

Bicuculline
Brain
Insula of Reil
Valium
Gamma-Aminobutyric Acid, Zinc Salt (2:1)
Tissue Membrane
Muscimol
Receptors, Drug

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.